Aldeyra Therapeutics Inc ALDX:NASDAQ

Last Price$3.57Cboe Real-Time Last Sale as of 11:06AM ET 1/18/22
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change-0.21(5.56%)
Bid (Size)$3.56 (400)
Ask (Size)$3.58 (430)
Day Low / High$3.60 - 3.76
Volume258.2 K
  • Latest Stories
  • Commentary and Analysis
Aldeyra Says Reproxalap Demonstrates Symptom Improvement Over Xiidra in Mid-Stage Trial in Dry Eye Disease
9:51AM ET 1/11/2022 MT Newswires

Aldeyra Therapeutics (ALDX) said Tuesday that patient-reported ocular discomfort and itching were "statistically lower" with reproxalap compared with...

Aldeyra Therapeutics Completes Enrollment in Part 1 of Phase 3 Trial for Eye Disease Drug
9:59AM ET 1/04/2022 MT Newswires

Aldeyra Therapeutics (ALDX) said Tuesday it completed enrollment in the first part of the phase 3 trial of ADX-2191 in patients with proliferative...

--Berenberg Bank Adjusts Aldeyra Therapeutics PT to $28 From $32, Maintains Buy Rating
8:37AM ET 12/22/2021 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Sector Update: Health Care Stocks Edging Higher Near Tuesday Close
4:02PM ET 12/21/2021 MT Newswires

Health care stocks held small gains ahead of Tuesday's close, with the NYSE Health Care Index rising 0.4% and the Health Care Select Sector SPDR ETF (XLV)...

Sector Update: Health Care Stocks Slightly Higher Tuesday
1:28PM ET 12/21/2021 MT Newswires

Health care stocks were edging higher Tuesday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR ETF (XLV) both up about...

--Alliance Global Partners Adjusts Aldeyra Therapeutics PT to $24 From $32, Maintains Buy Rating
1:05PM ET 12/21/2021 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Top Midday Decliners
12:51PM ET 12/21/2021 MT Newswires

Aldeyra Therapeutics (ALDX) was sinking over 51%, staying within close range of its drop to its lowest share price since July 2020, after it said its...

Aldeyra Therapeutics Says Phase 3 Trial of Dry Eye Disease Treatment Misses Primary Endpoint
11:30AM ET 12/21/2021 MT Newswires

Aldeyra Therapeutics (ALDX) said late Monday the phase 3 Tranquility trial of its investigational product candidate to treat dry eye disease missed the...

--Oppenheimer Adjusts Aldeyra Therapeutics' Price Target to $10 From $16, Maintains Outperform Rating
10:07AM ET 12/21/2021 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Wall Street Set for Positive Open as Nike, Micron Earnings Lift Sentiment
9:32AM ET 12/21/2021 MT Newswires

US stocks were set for a higher open Tuesday, supported by upbeat earnings from apparel company Nike (NKE) and chipmaker Micron Technologies (MU). The Dow...